title: [Angiosarcoma of the breast. Apropos of 8 cases and review of the literature].
abstract: The 8 cases of primary breast angiosarcoma which were diagnosed, treated and had their follow-up at the Gustave-Roussy Institute between 1954 and 1995 are reported. The age at presentation ranged from 32 to 68 years. In 4 patients the vascular nature of their mammary lesion was conspicuous by a violaceous discolorations of the overlying skin. No patient had enlarged ipsilateral axillary lymph nodes. One patient had metastases. In 2 out of 5 patients who had a partial surgical or fine-needle biopsy before treatment, the diagnosis was missed, and adequate treatment was unduly delayed. The tumor most often presents as an ill defined area made of dense endothelium-lined papillae. A remarkable picture of "soap bubbles" has been identified in 4 cases. The "meshes" of fatty areas appear to be reinforced as they are infiltrated by tumor cells. This appearance may be specific of mammary angiosarcoma. By the French Cancer Centers' grading system for soft tissue sarcomas in general, grade is III in 3 tumors, II in 2 tumors, I in 3 tumors. Five tumors were treated by total mastectomy only. In 3 cases a total mastectomy was followed by radiation therapy to the chest wall. At diagnosis a chemotherapy was administered only to the patient who had metastases. Median disease-free survival was 9 months. Median overall survival was 13 months. From a review of the literature a simple mastectomy appears to be necessary as well as enough for local treatment. Patients with a grade III angiosarcoma of the breast should be included into a therapeutical trial of adjuvant chemotherapy for soft tissue sarcomas in general.
authors.affiliation: Département de médecine, Institut Gustave-Roussy, rue Camille-Desmoulins, Villejuif, France.
authors.forename: J L
authors.initials: JL
authors.lastname: Molitor
authors.forename: A
authors.initials: A
authors.lastname: Llombart
authors.forename: J M
authors.initials: JM
authors.lastname: Guinebretière
authors.forename: L
authors.initials: L
authors.lastname: Zemoura
authors.forename: M
authors.initials: M
authors.lastname: Spielmann
authors.forename: G
authors.initials: G
authors.lastname: Contesso
authors.forename: F
authors.initials: F
authors.lastname: de Vathaire
authors.forename: L
authors.initials: L
authors.lastname: Zelek
authors.forename: L
authors.initials: L
authors.lastname: Kaylitalire
authors.forename: T
authors.initials: T
authors.lastname: Le Chevalier
authors.forename: J
authors.initials: J
authors.lastname: Genin
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006394:Hemangiosarcoma / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D006801:Humans; D015409:Mastectomy, Radical; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D016609:Neoplasms, Second Primary / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D010808:Physical Examination; D011247:Pregnancy; D011379:Prognosis; D016019:Survival Analysis; D016896:Treatment Outcome